Dicerna Pharma (DRNA) Tops Q3 EPS by 17c
Tweet
Share
E-mailGet Alerts DRNA Hot Sheet
Join SI Premium – FREE
Dicerna Pharma (NASDAQ: DRNA) reported Q3 EPS of ($0.68), $0.17 better than the analyst estimate of ($0.85).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
- Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
